[1]
|
Kirby, A. and Iturriza-Gómara, M. (2012) Norovirus diagnostics: Options, applications and interpretations. Expert Review of Anti-Infective Therapy, 10, 423-433.
doi:10.1586/eri.12.21
|
[2]
|
Holtz, L.R., Neill, M.A. and Tarr, P.I. (2009) Acute bloody diarrhea: A medical emergency for patients of all ages. Gastroenterology, 136, 1887-1898.
doi:10.1053/j.gastro.2009.02.059
|
[3]
|
Nakamura, T., Sakai, K. and Matsumoto, K. (2011) He patocyte growth factor twenty years on: Much more than a growth factor. Journal of Gastroenterology and Hepatology, 26, 188-202.
doi:10.1111/j.1440-1746.2010.06549.x
|
[4]
|
Doeppner, T.R., Kaltwasser, B., ElAli, A., Zechariah, A., Hermann, D.M. and Bahr, M. (2011) Acute hepatocyte growth factor treatment induces long-term neuroprotection and stroke recovery via mechanisms involving neural precursor cell proliferation and differentiation. Journal of Cerebral Blood Flow Metabolism, 31, 1251-1262.
doi:10.1038/jcbfm.2010.211
|
[5]
|
Liedberg, B., Nylander, C. and Lundstrom, I. (1995) Biosensing with surface plasmon resonance-how it all started. Journal of Biosensors and Bioelectronics, 10, 1-9.
|
[6]
|
Nayeri, F., Xu, J., Abdiu, A., Nayeri, T., Aili, D., Liedberg, B., et al. (2006) Autocrine production of biologically active hepatocyte growth factor (HGF) by injured human skin. Journal of Dermatological Sciences, 43, 49 56. doi:10.1016/j.jdermsci.2006.03.004
|
[7]
|
Nayeri, F., Nayeri, T., Aili, D., Brudin, L. and Liedberg, B. (2008) Clinical impact of real-time evaluation of the biological activity and degradation of hepatocyte growth factor. Journal of Growth Factors, 26, 163-171.
doi:10.1080/08977190802128083
|
[8]
|
Berger, M., Welle, A., Gottwald, E., Rapp, M. and Lange, K. (2010) Biosensors coated with sulfated polysaccharides for the detection of hepatocyte growth factor/scatter factor in cell culture medium. Journal of Biosensors and Bioelectronics, 26, 1706-1709.
doi:10.1016/j.bios.2010.07.065
|
[9]
|
Yamaji, N., Ido, A., Moriuchi, A., Numata, M., Setoyama, H., Tamai, T., et al. (2011) Hepatocyte growth factor ameliorates mucosal injuries leading to inhibition of colon cancer development in mice. Oncology Reports, 26, 335-341.
|
[10]
|
Linares, P.M. and Gisbert, J.P. (2011) Role of growth factors in the development of lymphangiogenesis driven by inflammatory bowel disease: A review. Journal of Inflammatory Bowel Diseases, 17, 1814-1821.
doi:10.1002/ibd.21554
|
[11]
|
Cammarota, R., Bertolini, V., Pennesi, G., Bucci, E.O., Gottardi, O., Garlanda, C., et al. (2010) The tumor microenvironment of colorectal cancer: Stromal TLR-4 expression as a potential prognostic marker. Journal of Translational Medicine, 8, 112-128.
doi:10.1186/1479-5876-8-112
|
[12]
|
Nayeri, F., Almer, S., Brudin, L., Nilsson, I., Akerlind, B. and Forsberg, P. (2003) High hepatocyte growth factor levels in faeces during acute infectious gastroenteritis. Scandinavian Journal of Infectious Diseases, 35, 858 862. doi:10.1080/00365540310016484
|
[13]
|
Bergeron, J.A. and Singer, M. (1958) Metachromasy: An experimental and theoretical reevaluation. Journal of Biophysical and Biochemical Cytology, 4, 433-457.
doi:10.1083/jcb.4.4.433
|
[14]
|
Fangous, M.S., Kerspern, H., Moineau, M.P., Kerlan, V., Alavi, Z. and Carre, J.L. (2012) The hook effect in calcitonin immunoradiometric assay: A case report. Annual Endocrinology Journal, 73, 552-555.
doi:10.1016/j.ando.2012.07.681
|
[15]
|
Pham, N.A., Morrison, A., Schwock, J., Aviel-Ronen, S., Iakovlev, V., Tsao, M.S., et al. (2007) Quantitative image analysis of immunohistochemical stains using a CMYK color model. Journal of Diagnostic Pathology, 2, 8-17.
doi:10.1186/1746-1596-2-8
|
[16]
|
L?nn, J., Starkhammar, J.C., K?lvegren, H., Brudin, L., Skoglund, C., Garvin, P., et al. (2012) Hepatocyte growth factor in patients with coronary artery disease and its relation to periodontal condition. Results in Immunology, 2, 7-12. doi:10.1016/j.rinim.2011.12.002
|
[17]
|
L?nn, J., Shahzad, F., Uhlin, F., Bengtsson, T., Almroth, G. and Nayeri, F. (2012) High concentration but low biological activity of hepatocyte growth factor in patients with chronic renal failure. Advances in Bioscience and Biotechnology, 3, 516-523. doi:10.4236/abb.2012.324068
|
[18]
|
Lonn, J., Almroth, G., Brudin, L. and Nayeri, F. (2012) An antithrombin III product containing biologically active hepatocyte growth factor may be beneficial in deep ulcer infections. Cytokine, 60, 478-486.
doi:10.1016/j.cyto.2012.05.023
|
[19]
|
Nayeri, F., Nilsson, I., Brudin, L. and Almer, S. (2004) Stability of faecal hepatocyte growth factor determination. Scandinavian Journal of Clinical and Laboratory Investigations, 64, 589-597. doi:10.1080/00365510410002850
|
[20]
|
Nayeri, F., Aili, D., Nayeri, T., Xu, J., Almer, S., Lundstrom, I., et al. (2005) Hepatocyte growth factor (HGF) in fecal samples: Rapid detection by surface plasmon resonance. BMC Journal of Gastroenterolology, 5, 13-20.
doi:10.1186/1471-230X-5-13
|
[21]
|
Bean, N.H., Griffin, P.M., Goulding, J.S. and Ivey, C.B. (1990) Foodborne disease outbreaks, 5-year summary, 1983-1987. MMWR CDC Surveillance Summaries, 39, 15-57.
|
[22]
|
Kostakis, I.D., Cholidou, K.G., Vaiopoulos, A.G., Vlachos, I.S., Perrea, D. and Vaos, G. (2012) Fecal calprotectin in pediatric inflammatory bowel disease: A systematic review. Journal of Digestive Diseases and Sciences, in Press. doi:10.1007/s10620-012-2347-5
|